シンバイオ製薬【4582】 固定資産合計の推移
機能の使い方
|
（単位：百万円）
|
固定資産合計
|
前年比（％）
|
|
2Q26
|
41
|
-3.2%
|
|
1Q26
|
39
|
+0.3%
|
|
4Q25
|
43
|
-1.9%
|
|
3Q25
|
44
|
-0.1%
|
|
2Q25
|
43
|
-3.9%
|
|
1Q25
|
39
|
-55.3%
|
|
4Q24
|
44
|
-49.7%
|
|
3Q24
|
44
|
-92.1%
|
|
2Q24
|
44
|
-95.8%
|
|
1Q24
|
87
|
-91.7%
|
|
4Q23
|
87
|
-92.2%
|
|
3Q23
|
557
|
-63.4%
|
|
2Q23
|
1,054
|
-24.8%
|
|
1Q23
|
1,054
|
-27.1%
|
|
4Q22
|
1,120
|
-34.3%
|
|
3Q22
|
1,522
|
+250.6%
|
|
2Q22
|
1,403
|
+228.3%
|
|
1Q22
|
1,446
|
+230.8%
|
|
4Q21
|
1,705
|
+271.2%
|
|
3Q21
|
434
|
-6.1%
|
|
2Q21
|
427
|
-5.7%
|
|
1Q21
|
437
|
+2.3%
|
|
4Q20
|
459
|
+18.9%
|
|
3Q20
|
462
|
+34.6%
|
|
2Q20
|
452
|
+51.3%
|
|
1Q20
|
427
|
+97.1%
|
|
4Q19
|
386
|
+92.3%
|
|
3Q19
|
343
|
+81.1%
|
|
2Q19
|
299
|
+49.1%
|
|
1Q19
|
216
|
-2.1%
|
|
4Q18
|
200
|
-6.9%
|
|
3Q18
|
189
|
-7.2%
|
|
2Q18
|
200
|
+3.1%
|
|
1Q18
|
221
|
+14.5%
|
|
4Q17
|
215
|
+11.6%
|
|
3Q17
|
204
|
+16.0%
|
|
2Q17
|
194
|
+20.7%
|
|
1Q17
|
193
|
+28.9%
|
|
4Q16
|
193
|
+22.8%
|
|
3Q16
|
176
|
+11.9%
|
|
2Q16
|
161
|
-
|
|
1Q16
|
150
|
-
|
|
4Q15
|
157
|
-3.8%
|
|
3Q15
|
157
|
-
|
|
4Q14
|
163
|
-
|